33 C
Delhi
Tuesday, September 29, 2020

New Covid-19 drug gets DCGI’s nod for human trial

- Advertisement -

Covid 19 vaccine likely in 2020, production will starty by 2021 endBy Aakanksha Khajuria, (IANS) Amid the raging coronavirus pandemic, PNB Vesper Life Science Private Limited on Friday received approval from the Drug Controller General of India to conduct the clinical trial of their drug on Covid-19 patients.

Speaking to IANS about the breakthrough innovation, CEO of PNB Vesper Life Science Private Limited P.N. Balaram said that this is a very big step for mankind in the fight against the Covid-19 pandemic. The molecule has shown remarkable results in reducing lung inflammation and acute respiratory distress syndrome.

The Indian Pharma Research company claimed that if their propriety drug PNB-001 — Baladol — works successfully in Covid-19 patients, it would be the “first new chemical entity in the world for treatment of the disease”.

The drug has shown positive results in all the initial preclinical studies. The Phase 2, which would prove the efficacy of the molecule, will now be conducted at BMJ Medical College in Pune on 40 moderate patients on oxygen support, within 60 days.

“In Covid-19, the main symptoms are pyrexia, body pain and inflammation in the lung and we lose patients mainly because of cytokine storms and ARDS. We have proved in the pre-clinical studies, our drug is effective in reducing fever, body pain and inflammation,” said CEO Balram.

He said that with the drug, the death rate also reduced to 80 percent, whereas Dexamethasone drug, currently the most popular medicine in COVID-19 treatment in the world, only gives 20 per cent death reduction.

“Considering the novel mechanism of our molecule,A we expect much better results in the clinical trials compared with Dexamethasone. It means the mortality rate can be reduced considerably by using Baladol,” the CEO said.

According to the company, Baladol was found to be extremely safe in a Phase 1 clinical trial thereby leading to subsequent Phase 2 and 3 trials. It was tested in 74 healthy subjects at low, medium and high doses over a course of period. In the pre-clinical models, and found to be highly effective in inflammation compared with steroids.

After the completion of the phase 2 trials, a larger population, approximately 350 patients will be enrolled across the country in six medical Colleges for the Phase 3 trials. The molecule has already been patented and the related Intellectual Property Rights (IPRs) have been secured in the US, Europe and rest of the world.

Further, the US FDA has shown interest in the drug and the discussions with USFDA are in the final stages. Other than this, discussions have already been initiated with the UK Government to include the drug in the ongoing Covid-19 clinical trials. PNB Vesper’s UK Scientific Team headed by Eric Lattmann is coordinating the UK developments.

“PNB-001 has been found to be twenty times more efficacious than aspirin in the antipyretic and pain studies. It is also proved that the cytokine storms and spleen size reduced significantly,” Lattmann said.

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

Rajnath launches startup challenge to promote self-reliance in defence sector

New Delhi, Sep 29 (IANS) Union Defence Minister Rajnath Singh on Tuesday launched a startup challenge to achieve self-reliance in the military sector under...

Xiaomi’s Mi India forays into smart home category in India

New Delhi, Sep 29 (IANS) Xiaomi subsidiary Mi India on Tuesday forayed into the smartwatch and smart speaker categories, along with launching other affordable...

Profit booking, global cues subdue markets, banking stocks fall

Mumbai, Sep 29 (IANS) Profit booking, along with volatile global cues, subdued the Indian equity markets on Tuesday, with both the BSE Sensex and...

Digital transformation top priority for 9 in 10 large firms: TCS

New Delhi, Sep 29 (IANS) While 68 per cent of companies have seen revenue declines amid the pandemic, nine out of 10 large enterprises...

India does not need more Smart Cities, says Urban Affairs Secy

New Delhi, Sep 29 (IANS) Even as work is underway on building 100 Smart Cities across the country, there is no need for more as...

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

87million were likely exposed to Covid-19, 1 in 15 had antibodies

New Delhi, Sep 29 (IANS) The key findings of the second round of sero-survey conducted by the Indian Council of Medical Research (ICMR) suggested...

Health ministry launches web portal for COVID-19 vaccine updates

New Delhi, Sep 28 (PTI) The Union Health Ministry on Monday launched a web portal that will provide all important information on COVID-19, vaccine...

Dependence of global supply chain on single source exposed: PM Modi

New Delhi, Sep 28 (PTI) The coronavirus pandemic has shown the risk involved in excessive dependence of the global supply chain on any single...

Over 3,000 vaccinated against coronavirus in Moscow

Moscow, Sep 28 (IANS) More than 3,000 people in Moscow have been vaccinated against the novel coronavirus, the media has reported."More than 3,000 volunteers...

Trending News In India

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

Xiaomi’s Mi India forays into smart home category in India

New Delhi, Sep 29 (IANS) Xiaomi subsidiary Mi India on Tuesday forayed into the smartwatch and smart speaker categories, along with launching other affordable...

Profit booking, global cues subdue markets, banking stocks fall

Mumbai, Sep 29 (IANS) Profit booking, along with volatile global cues, subdued the Indian equity markets on Tuesday, with both the BSE Sensex and...

Digital transformation top priority for 9 in 10 large firms: TCS

New Delhi, Sep 29 (IANS) While 68 per cent of companies have seen revenue declines amid the pandemic, nine out of 10 large enterprises...

India does not need more Smart Cities, says Urban Affairs Secy

New Delhi, Sep 29 (IANS) Even as work is underway on building 100 Smart Cities across the country, there is no need for more as...

Serum Institute to manufacture 200mn doses of Covid-19 vaccine

New Delhi, Sep 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi...

Trending Showbiz

NCB seizes phones of Deepika, Rakul, Simone, Karishma in drugs case

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB), which quizzed Bollywood actors Rakul Preet Singh, Deepika Padukone, her former manager Karishma Prakash, and...

NCB quizzes Deepika, Sara, Shraddha in drug case related to SSR death

Mumbai, Sep 26 (IANS) The Narcotics Control Bureau (NCB) on Saturday questioned Bollywood divas Deepika Padukone, Sara Ali Khan, Shraddha Kapoor for several hours...

‘CBI delay in converting abetment to suicide to murder frustrating’

Mumbai, Sep 25 (IANS) Vikas Singh, family lawyer of late actor Sushant Singh Rajput, on Friday stated that the delay being by Central Bureau...

NCB questions Rakul, Deepika’s ex-manager, Dharma Productions honcho

Mumbai, Sep 25 (IANS) The Narcotics Control Bureau (NCB) on Friday is questioning Bollywood actor Rakul Preet Singh, Dharma Productions executive producer Kshitij Ravi...

Famed singer S.P. Balasubrahmanyam succumbs to Covid-19

Chennai, Sep 25 (IANS) Famed playback singer and Padma awardee S.P. Balasubrahmanyam, or popularly SPB or Balu in the movie world and who has...

Trending Sports

Kohli wins Super Over thriller for RCB, Kishan’s 99 in vain

Dubai, Sep 29 (IANS/GloFans) In yet another roller-coaster contest, Royal Challengers Bangalore (RCB) edged out Mumbai Indians (MI) in a Super Over tie-breaker - the...

ICC gets recognition for two digital initiatives in Leaders in Sports Awards

Dubai, Sep 28 (PTI) The International Cricket Council (ICC) has been recognised for its twin digital initiatives at the prestigious Leaders in Sports Awards...

Played nearly 500 games, can speak to any player says Ganguly

Kolkata, Sep 28 (PTI) His nearly "500 international match experience" gives him the right to speak and guide any player "be it Shreyas Iyer...

Went through rigorous physical, mental transformation for 1996 Olympics, says Paes

New Delhi, Sep 28 (IANS) The year was 1996 and no Indian had won an individual medal at the Olympics 44 years prior to...

Sensational Tewatia hits five sixes in an over as RR defeats KXIP

Sharjah, Sep 28 (PTI) Rahul Tewatia struck five sixes in an over at the fag end of the match as Rajasthan Royals recorded the...

Gill stars as clinical KKR thrash SRH by 7 wkts

Abu Dhabi, Sep 27 (IANS/GloFans) Opener Shubhman Gill's unbeaten 70-run knock along with Eoin Morgan's 42 not out guided Kolkata Knight Riders (KKR) to...

Latest Trending News In India

Rajnath launches startup challenge to promote self-reliance in defence sector

New Delhi, Sep 29 (IANS) Union Defence Minister Rajnath Singh on Tuesday launched a startup challenge to achieve self-reliance in the military sector under...

Xiaomi’s Mi India forays into smart home category in India

New Delhi, Sep 29 (IANS) Xiaomi subsidiary Mi India on Tuesday forayed into the smartwatch and smart speaker categories, along with launching other affordable...

Profit booking, global cues subdue markets, banking stocks fall

Mumbai, Sep 29 (IANS) Profit booking, along with volatile global cues, subdued the Indian equity markets on Tuesday, with both the BSE Sensex and...

Digital transformation top priority for 9 in 10 large firms: TCS

New Delhi, Sep 29 (IANS) While 68 per cent of companies have seen revenue declines amid the pandemic, nine out of 10 large enterprises...

India does not need more Smart Cities, says Urban Affairs Secy

New Delhi, Sep 29 (IANS) Even as work is underway on building 100 Smart Cities across the country, there is no need for more as...